Clinical Trials Browser

Phase 1 × Hot Flashes × N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine × Clear all

NCT04080297 2020-02-28

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Phase 1 Completed

21 enrolled 13 charts

Breast Neoplasms, Hot Flashes